RxCentric.com, Inc.

Name: RxCentric.com, Inc.
Brand: Veradigm

Leader

Driving value through its unique combination of platforms, data, expertise, connectivity, and scale.

Est 2006|Valuation $522.7M|Raised $3.3B|8 Ref Customers

LinkedIn 178K|Website|Web traffic 218K|FTEs 1,844|HQ Chicago, Illinois, US

MarketsAPI Management

01Competitive Landscape

Narrative competitive analysis

- Veradigm's RxTruePrice aligns with market trends toward real-time benefit checks and enabling cost conversations at prescribing time. - Veradigm emphasizes workflow integration and automation (ePA, PDMP, EPCS), which can reduce fragmentation for providers when these capabilities are implemented successfully. - Alternatives may offer clearer published pricing and packaging (reducing procurement friction) or may be preferred where an organization requires a narrowly scoped, modular prescribing component rather than a broader vendor relationship. - Direct, head-to-head customer evidence comparing ePrescribe implementations across vendors is limited in the public materials reviewed; procurement teams should plan controlled evaluations and pilots.

	Veradigm ePrescribe / RxTruePrice	iPrescribe	DoseSpot / Treat
Starting Price	Advertised as a per-prescriber monthly subscription; starting in the low tens of dollars per prescriber per month	Published tiered pricing with mobile and practice licenses, with per-license monthly billing implied	Listed on comparison sites at a comparable per-month subscription magnitude (vendor confirmation recommended)
Recommended for	Practices seeking integrated prescribing with real-time price transparency in the prescribing workflow	Smaller practices or providers seeking published tiering and mobile/desktop options	Organizations embedding the DoseSpot stack or evaluating modular prescribing components alongside clinical workflows
Key Strength	Patient-specific price transparency (RxTruePrice) and vendor claims of broad healthcare connectivity	Published tiers and packaging that can simplify procurement for small practices	Presence as an embedded e-prescribing option; suitability varies by buyer and integration context
Key Weakness	Review and complaint evidence indicates potential support and billing risks; mobile app satisfaction concerns; limited public detail on product-specific compliance artifacts	Real-time benefit coverage depth can vary by integration; requires validation in each deployment market	Pricing and feature parity on comparison sites may be incomplete; feature availability depends on bundle and integration choices

01Competitive Landscape

Narrative competitive analysis

Veradigm's RxTruePrice aligns with market trends toward real-time benefit checks and enabling cost conversations at prescribing time.
Veradigm emphasizes workflow integration and automation (ePA, PDMP, EPCS), which can reduce fragmentation for providers when these capabilities are implemented successfully.
Alternatives may offer clearer published pricing and packaging (reducing procurement friction) or may be preferred where an organization requires a narrowly scoped, modular prescribing component rather than a broader vendor relationship.
Direct, head-to-head customer evidence comparing ePrescribe implementations across vendors is limited in the public materials reviewed; procurement teams should plan controlled evaluations and pilots.

	Veradigm ePrescribe / RxTruePrice	iPrescribe	DoseSpot / Treat
Starting Price	Advertised as a per-prescriber monthly subscription; starting in the low tens of dollars per prescriber per month	Published tiered pricing with mobile and practice licenses, with per-license monthly billing implied	Listed on comparison sites at a comparable per-month subscription magnitude (vendor confirmation recommended)
Recommended for	Practices seeking integrated prescribing with real-time price transparency in the prescribing workflow	Smaller practices or providers seeking published tiering and mobile/desktop options	Organizations embedding the DoseSpot stack or evaluating modular prescribing components alongside clinical workflows
Key Strength	Patient-specific price transparency (RxTruePrice) and vendor claims of broad healthcare connectivity	Published tiers and packaging that can simplify procurement for small practices	Presence as an embedded e-prescribing option; suitability varies by buyer and integration context
Key Weakness	Review and complaint evidence indicates potential support and billing risks; mobile app satisfaction concerns; limited public detail on product-specific compliance artifacts	Real-time benefit coverage depth can vary by integration; requires validation in each deployment market	Pricing and feature parity on comparison sites may be incomplete; feature availability depends on bundle and integration choices